The founder of SafeDecisions LLC, Herbert Roy Zucker, has led the company in an executive capacity since 2003, focusing on delivering innovative techniques for personal protection and peace of mind in today's dynamic and unsafe environment. In addition, he serves as a Senior Consultant at Merrill Lynch. Dedicated to giving back to his community, Herbert Roy Zucker is an active volunteer for various organizations, including the New York Children's Medical Fund.
In the final quarter of 2021, Omicron, the coronavirus variant, posed the most severe threat. All ages can contract the variant, and the symptoms are the same as those of earlier variants, which include severe acute respiratory syndrome and pneumonia. Older adults are more susceptible to severe complications like death. On the other hand, children typically have mild symptoms, although they may also develop significant respiratory issues from long-term infection.
There were only a few cases of severe symptoms in children because, contrary to adults, the immune systems of children are more innate than adaptive. Innate immunity refers to immunity to certain diseases due to the body’s natural capacity to fight infections. Adaptive immunity, on the other hand, is acquired from previous exposure to a disease. In this case, the body had developed a means of fighting the infection. Since the omicron variant and coronavirus, in general, are novel pandemics, it’s a bit obvious why adaptive immunity stands little chance against the infection.
